133 related articles for article (PubMed ID: 35176912)
1. Changes in antidepressant use in Australia: A nationwide analysis (2015-2021).
de Oliveira Costa J; Gillies MB; Schaffer AL; Peiris D; Zoega H; Pearson SA
Aust N Z J Psychiatry; 2023 Jan; 57(1):49-57. PubMed ID: 35176912
[TBL] [Abstract][Full Text] [Related]
2. Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID-19 pandemic, 2013-2021: a retrospective cohort study.
Wood SJ; Ilomäki J; Gould J; Tan GS; Raven M; Jureidini JN; Grzeskowiak LE
Med J Aust; 2023 Jul; 219(1):18-25. PubMed ID: 37182907
[TBL] [Abstract][Full Text] [Related]
3. Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey.
Hammarberg K; Tran T; Kirkman M; Fisher J
BMJ Open; 2020 Nov; 10(11):e042696. PubMed ID: 33234659
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study.
Jack RH; Hollis C; Coupland C; Morriss R; Knaggs RD; Butler D; Cipriani A; Cortese S; Hippisley-Cox J
PLoS Med; 2020 Jul; 17(7):e1003215. PubMed ID: 32697803
[TBL] [Abstract][Full Text] [Related]
5. The effects of COVID-19 on the dispensing rates of antidepressants and benzodiazepines in Canada.
Uthayakumar S; Tadrous M; Vigod SN; Kitchen SA; Gomes T
Depress Anxiety; 2022 Feb; 39(2):156-162. PubMed ID: 34843627
[TBL] [Abstract][Full Text] [Related]
6. Effects of COVID-19 pandemic on anxiety and depression in primary care: A retrospective cohort study.
Stephenson E; O'Neill B; Kalia S; Ji C; Crampton N; Butt DA; Tu K
J Affect Disord; 2022 Apr; 303():216-222. PubMed ID: 35139415
[TBL] [Abstract][Full Text] [Related]
7. Impact of the COVID-19 pandemic on antidepressant and antipsychotic use among children and adolescents: a population-based study.
Antoniou T; Pajer K; Gardner W; Penner M; Lunsky Y; Tadrous M; Mamdani M; Gozdyra P; Juurlink DN; Gomes T
Front Pediatr; 2023; 11():1282845. PubMed ID: 38146536
[TBL] [Abstract][Full Text] [Related]
8. Prescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approach.
Estrela M; Silva TM; Gomes ER; Piñeiro M; Figueiras A; Roque F; Herdeiro MT
J Epidemiol Community Health; 2022 Apr; 76(4):335-340. PubMed ID: 34625519
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 Pandemic on the Use of Antidepressant and Antianxiety Pharmaceuticals as Well as Sick Leave in Poland.
Krupa D; Czech M; Pinkas J; Mosiołek A
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206325
[TBL] [Abstract][Full Text] [Related]
10. Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure.
Brett J; Karanges EA; Daniels B; Buckley NA; Schneider C; Nassir A; Zoega H; McLachlan AJ; Pearson SA
Aust N Z J Psychiatry; 2017 Oct; 51(10):990-999. PubMed ID: 28758432
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant use and its relationship with current symptoms in a population-based sample of older Australians.
Chitty KM; Butterworth P; Batterham PJ
J Affect Disord; 2019 Nov; 258():83-88. PubMed ID: 31398595
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant Dispensing to US Adolescents and Young Adults: 2016-2022.
Chua KP; Volerman A; Zhang J; Hua J; Conti RM
Pediatrics; 2024 Mar; 153(3):. PubMed ID: 38404197
[TBL] [Abstract][Full Text] [Related]
13. Depression, anxiety, and antidepressant treatment in women: association with in vitro fertilization outcome.
Cesta CE; Viktorin A; Olsson H; Johansson V; Sjölander A; Bergh C; Skalkidou A; Nygren KG; Cnattingius S; Iliadou AN
Fertil Steril; 2016 Jun; 105(6):1594-1602.e3. PubMed ID: 26920258
[TBL] [Abstract][Full Text] [Related]
14. Increased incident rates of antidepressant use during the COVID-19 pandemic: interrupted time-series analysis of a nationally representative sample.
Frangou S; Travis-Lumer Y; Kodesh A; Goldberg Y; New F; Reichenberg A; Levine SZ
Psychol Med; 2023 Aug; 53(11):4943-4951. PubMed ID: 35680620
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant use and depressive symptomatology among older people from the Australian Longitudinal Study of Ageing.
Zhang Y; Chow V; Vitry AI; Ryan P; Roughead EE; Caughey GE; Ramsay EN; Gilbert AL; Esterman A; Luszcz MA
Int Psychogeriatr; 2010 May; 22(3):437-44. PubMed ID: 20105349
[TBL] [Abstract][Full Text] [Related]
16. Prescriptions of antidepressants and anxiolytics in France 2012-2022 and changes with the COVID-19 pandemic: interrupted time series analysis.
De Bandt D; Haile SR; Devillers L; Bourrion B; Menges D
BMJ Ment Health; 2024 Feb; 27(1):. PubMed ID: 38413052
[TBL] [Abstract][Full Text] [Related]
17. Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic.
Tiger M; Castelpietra G; Wesselhoeft R; Lundberg J; Reutfors J
Transl Psychiatry; 2024 Apr; 14(1):175. PubMed ID: 38575574
[TBL] [Abstract][Full Text] [Related]
18. Trajectories of depression and anxiety symptoms during the COVID-19 pandemic in a representative Australian adult cohort.
Batterham PJ; Calear AL; McCallum SM; Morse AR; Banfield M; Farrer LM; Gulliver A; Cherbuin N; Rodney Harris RM; Shou Y; Dawel A
Med J Aust; 2021 Jun; 214(10):462-468. PubMed ID: 33899939
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic.
Shi L; Lu ZA; Que JY; Huang XL; Liu L; Ran MS; Gong YM; Yuan K; Yan W; Sun YK; Shi J; Bao YP; Lu L
JAMA Netw Open; 2020 Jul; 3(7):e2014053. PubMed ID: 32609353
[TBL] [Abstract][Full Text] [Related]
20. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19.
Rabeea SA; Merchant HA; Khan MU; Kow CS; Hasan SS
Daru; 2021 Jun; 29(1):217-221. PubMed ID: 33715138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
